Device Trial Radar · NCT02112877
VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction
Last checked: Nov 20, 2026Latest source record: Apr 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
Jun 26, 2014
Primary completion
Dec 5, 2017
Study completion Dec 18, 2020
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Apr 14, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, single arm, non-randomized study to define safety and efficacy of the Veniti Vici™ Venous Stent System in relation to pre-defined Objective Performance goals. A maximum of 200 patients at up to 45 centers worldwide will be enrolled. Thirty (30) feasibility patients will be enrolled at approximately 7-10 centers and 170 pivotal patients will be enrolled at approximately 45 centers worldwide. The follow-up period is 36 months.
Conditions
- Chronic Venous Disorder
- Venous Outflow Obstruction
- Symptomatic Venous Outflow Obstruction of Iliofemoral Vein
Interventions
Veniti Vici™ Venous Stent SystemDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Major Adverse Events (MAE)Time frame: 30 days
- Percentage of Participants That Demonstrated Primary PatencyTime frame: 12 months post-intervention
Locations
24 sites in 7 countries. Site status is shown where the registry gives one.
Abrazo Arizona Heart Hospital
Phoenix, Arizona
Healthfinity PLCC
Scottsdale, Arizona
Arkansas Site Management Services, LLC
Little Rock, Arkansas
21 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.